Literature DB >> 9616227

Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

C Brander1, K E Hartman, A K Trocha, N G Jones, R P Johnson, B Korber, P Wentworth, S P Buchbinder, S Wolinsky, B D Walker, S A Kalams.   

Abstract

Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A*0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A*0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A*0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A*0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of immunodominant CTL responses present during chronic HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616227      PMCID: PMC508845          DOI: 10.1172/JCI2405

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

Review 1.  MHC molecules as peptide receptors.

Authors:  H G Rammensee; K Falk; O Rötzschke
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

2.  In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes.

Authors:  T Aebischer; D Moskophidis; U H Rohrer; R M Zinkernagel; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.

Authors:  J Driscoll; M G Brown; D Finley; J J Monaco
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

4.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.

Authors:  J Ruppert; J Sidney; E Celis; R T Kubo; H M Grey; A Sette
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

Review 5.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

6.  Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

Authors:  O O Yang; S A Kalams; M Rosenzweig; A Trocha; N Jones; M Koziel; B D Walker; R P Johnson
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

Authors:  P O de Campos-Lima; R Gavioli; Q J Zhang; L E Wallace; R Dolcetti; M Rowe; A B Rickinson; M G Masucci
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

8.  Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.

Authors:  Z W Chen; L Shen; M D Miller; S H Ghim; A L Hughes; N L Letvin
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

9.  Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.

Authors:  J T Safrit; C A Andrews; T Zhu; D D Ho; R A Koup
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

Authors:  A Carmichael; X Jin; P Sissons; L Borysiewicz
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  53 in total

1.  Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

Authors:  M Dalod; M Dupuis; J C Deschemin; C Goujard; C Deveau; L Meyer; N Ngo; C Rouzioux; J G Guillet; J F Delfraissy; M Sinet; A Venet
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Authors:  P J Goulder; C Brander; K Annamalai; N Mngqundaniso; U Govender; Y Tang; S He; K E Hartman; C A O'Callaghan; G S Ogg; M A Altfeld; E S Rosenberg; H Cao; S A Kalams; M Hammond; M Bunce; S I Pelton; S A Burchett; K McIntosh; H M Coovadia; B D Walker
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes.

Authors:  Michael S Bennett; Aviva Joseph; Hwee L Ng; Harris Goldstein; Otto O Yang
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

4.  Intrapatient escape in the A*0201-restricted epitope SLYNTVATL drives evolution of human immunodeficiency virus type 1 at the population level.

Authors:  Charles T T Edwards; Katja J Pfafferott; Philip J R Goulder; Rodney E Phillips; Edward C Holmes
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.

Authors:  Michael S Bennett; Hwee L Ng; Mirabelle Dagarag; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

Review 6.  Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Authors:  L Buonaguro; M L Tornesello; F M Buonaguro
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

7.  Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif.

Authors:  M A Altfeld; B Livingston; N Reshamwala; P T Nguyen; M M Addo; A Shea; M Newman; J Fikes; J Sidney; P Wentworth; R Chesnut; R L Eldridge; E S Rosenberg; G K Robbins; C Brander; P E Sax; S Boswell; T Flynn; S Buchbinder; P J Goulder; B D Walker; A Sette; S A Kalams
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.

Authors:  Angel Varela-Rohena; Peter E Molloy; Steven M Dunn; Yi Li; Megan M Suhoski; Richard G Carroll; Anita Milicic; Tara Mahon; Deborah H Sutton; Bruno Laugel; Ruth Moysey; Brian J Cameron; Annelise Vuidepot; Marco A Purbhoo; David K Cole; Rodney E Phillips; Carl H June; Bent K Jakobsen; Andrew K Sewell; James L Riley
Journal:  Nat Med       Date:  2008-11-09       Impact factor: 53.440

9.  Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.

Authors:  L Dorrell; T Dong; G S Ogg; S Lister; S McAdam; T Rostron; C Conlon; A J McMichael; S L Rowland-Jones
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission.

Authors:  Nobubelo K Ngandu; Cathal Seoighe; Konrad Scheffler
Journal:  Virol J       Date:  2009-10-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.